Kornelia Rynkiewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kornelia Rynkiewicz has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Natalia Bogusz
Independent Public Health Care Institution in Błonie (SGPZOZ in Błonie), Błonie, Poland
4 shared publications - Zofia Czaplińska-Paszek
Medical University of Warsaw, Warsaw, Poland
4 shared publications - Zofia Hałabuda
The Floriana Ceynowy Specialist Hospital in Wejherowo, Wejherowo, Poland
3 shared publications - Sławomir Paszek
Emergency Medicine Department, Medical University of Warsaw, Warsaw, Poland
2 shared publications - Anna Maria Zakrzewska
Central Clinical Hospital of the Medical University of Łódź, Łódź, Poland
1 shared publication - Karol Grela
Medical University of Warsaw, Warsaw, Poland
1 shared publication
Latest Publications
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
SUDDEN CARDIAC ARREST DURING MASS RUNNING EVENTS IN THE CONTEXT OF THE 2025 EUROPEAN RESUSCITATION COUNCIL GUIDLINES AND CURRENT SCIENTIFIC EVIDENCE
Introduction and objective: Sudden cardiac arrest (SCA) during outdoor sport training is a complication where a quick response from medical professionals is crucial for increasing chances of survival. In parallel with the global growth in running events, there is a need to implement new recommendations and technologies to improve prevention, detection, and treatment of SCA among runners. Review Methods: A comprehensive literature review was conducted, analyzing studies indexed in PubMed, Google Scholar, and the official ERC Guidelines from 2021 and 2025. Key findings: Recent data suggest that, although the number of SCA cases in mass running events has remained relatively stable over the past decade, running-related deaths have declined. These outcomes are likely attributable to significant improvements in emergency action planning, widespread AED availability, and enhanced first-aid education. There are also new ideas that can further improve those outcomes, not only in treatment but also in SCA prophylaxis. New preventive and diagnostic strategies, such as point-of-care blood gas analysis (POC BGA) and risk-profiling patient triage, focus primarily on early triage and smartwatch pulse-detector systems, offering a new perspective on more rapid detection of SCA during outdoor activity. Advances in treatment focus on optimizing the prehospital chain of survival through mobile AED teams, GPS-enabled responder coordination, and structured “field-of-play” protocols. Further research is needed to reduce the time to defibrillation and improve neurological outcomes during endurance events.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
Open AccessSUDDEN CARDIAC ARREST DURING MASS RUNNING EVENTS IN THE CONTEXT OF THE 2025 EUROPEAN RESUSCITATION COUNCIL GUIDLINES AND CURRENT SCIENTIFIC EVIDENCE
Introduction and objective: Sudden cardiac arrest (SCA) during outdoor sport training is a complication where a quick response from medical professionals is crucial for increasing chances of survival. In parallel with the global growth in running events, there is a need to implement new recommendations and technologies to improve prevention, detection, and treatment of SCA among runners. Review Methods: A comprehensive literature review was conducted, analyzing studies indexed in PubMed, Google Scholar, and the official ERC Guidelines from 2021 and 2025. Key findings: Recent data suggest that, although the number of SCA cases in mass running events has remained relatively stable over the past decade, running-related deaths have declined. These outcomes are likely attributable to significant improvements in emergency action planning, widespread AED availability, and enhanced first-aid education. There are also new ideas that can further improve those outcomes, not only in treatment but also in SCA prophylaxis. New preventive and diagnostic strategies, such as point-of-care blood gas analysis (POC BGA) and risk-profiling patient triage, focus primarily on early triage and smartwatch pulse-detector systems, offering a new perspective on more rapid detection of SCA during outdoor activity. Advances in treatment focus on optimizing the prehospital chain of survival through mobile AED teams, GPS-enabled responder coordination, and structured “field-of-play” protocols. Further research is needed to reduce the time to defibrillation and improve neurological outcomes during endurance events.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
DIAGNOSIS AND TREATMENT OF ACUTE ADRENAL CRISIS IN THE SETTING OF THE EMERGENCY DEPARTMENT - A LITERATURE REVIEW
Introduction and objective: Acute adrenal crisis (AAC) is a life-threatening condition, often under-recognized due to its rarity. Over the years, technological advances have occurred across many branches of medicine, including new solutions for diagnosing and treating AAC. However, they remain fragmented across the literature. In this review, we sought to systematically evaluate and summarize contemporary innovations that may help emergency medicine practitioners to be more confident in their diagnoses and, therefore, make more confident under-pressure clinical decisions. Review Methods: We searched the PubMed and Google Scholar databases, focusing on papers published between 2020 and 2025. Brief description of knowledge: Currently, AAC is treated empirically with hydrocortisone. Quick tests for cortisol levels are not widely available; diagnosis is based mainly on clinical symptoms and electrolyte disturbances. Summary: Developments in diagnostic approaches, such as saliva-based, aptamer-based point-of-care cortisol assays, may aid differential diagnosis of AAC in emergency departments (EDs) and reduce time to hydrocortisone administration.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
Open AccessDIAGNOSIS AND TREATMENT OF ACUTE ADRENAL CRISIS IN THE SETTING OF THE EMERGENCY DEPARTMENT - A LITERATURE REVIEW
Introduction and objective: Acute adrenal crisis (AAC) is a life-threatening condition, often under-recognized due to its rarity. Over the years, technological advances have occurred across many branches of medicine, including new solutions for diagnosing and treating AAC. However, they remain fragmented across the literature. In this review, we sought to systematically evaluate and summarize contemporary innovations that may help emergency medicine practitioners to be more confident in their diagnoses and, therefore, make more confident under-pressure clinical decisions. Review Methods: We searched the PubMed and Google Scholar databases, focusing on papers published between 2020 and 2025. Brief description of knowledge: Currently, AAC is treated empirically with hydrocortisone. Quick tests for cortisol levels are not widely available; diagnosis is based mainly on clinical symptoms and electrolyte disturbances. Summary: Developments in diagnostic approaches, such as saliva-based, aptamer-based point-of-care cortisol assays, may aid differential diagnosis of AAC in emergency departments (EDs) and reduce time to hydrocortisone administration.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
MALIGNANCY AND ATRIAL FIBRILLATION – HARDSHIPS TO MANAGE BLEEDING AND THROMBOEMBOLIC RISK
Atrial fibrillation (AF) and cancer are conditions that often coexist. Both of them, as well as their treatment, are connected with changes in coagulation processes, increasing the risk of bleeding or thromboembolic events. Despite that, the level of evidence supporting existing recommendations remains low. (Lyon et al., 2022) In this study, we focused on analyzing the existing literature on the assessment and management of bleeding and thromboembolic risk, with the aim of establishing an evidence-based approach to managing bleeding and thromboembolic risk in oncology patients with AF. Cancer is widely associated with a hypercoagulability state, but in the case of AF and stroke risk, it does not seem to be higher in general in comparison with non-cancer populations. It changes when individual cancer types are analyzed. As for the bleeding risk, many malignancies seem to increase it. Another challenge is that the existing risk scores often show lower predictive value for patients with recent malignancy. There is a need for individual assessment in every patient, but we lack the tools to make it easier for clinicians. Cardio-oncology guidelines addressing AF do exist, but the level of evidence supporting them remains low; thus, further research in this field is needed.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (1(49))
Open AccessMALIGNANCY AND ATRIAL FIBRILLATION – HARDSHIPS TO MANAGE BLEEDING AND THROMBOEMBOLIC RISK
Atrial fibrillation (AF) and cancer are conditions that often coexist. Both of them, as well as their treatment, are connected with changes in coagulation processes, increasing the risk of bleeding or thromboembolic events. Despite that, the level of evidence supporting existing recommendations remains low. (Lyon et al., 2022) In this study, we focused on analyzing the existing literature on the assessment and management of bleeding and thromboembolic risk, with the aim of establishing an evidence-based approach to managing bleeding and thromboembolic risk in oncology patients with AF. Cancer is widely associated with a hypercoagulability state, but in the case of AF and stroke risk, it does not seem to be higher in general in comparison with non-cancer populations. It changes when individual cancer types are analyzed. As for the bleeding risk, many malignancies seem to increase it. Another challenge is that the existing risk scores often show lower predictive value for patients with recent malignancy. There is a need for individual assessment in every patient, but we lack the tools to make it easier for clinicians. Cardio-oncology guidelines addressing AF do exist, but the level of evidence supporting them remains low; thus, further research in this field is needed.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
DIGITAL COGNITIVE-BEHAVIORAL THERAPY FOR INSOMNIA (dCBT-I) AS A METHOD OF HYPNOTIC MEDICATION REDUCTION USE
Introduction & objective: Insomnia, being an established health problem, has led to the development of various ways of treatment. While Cognitive Behavioral Therapy is a gold standard of insomnia treatment, due to cost and accessibility limitations, pharmacological methods remain widely used. The most commonly used drugs are benzodiazepines and Z-drugs, which, due to their adverse effects and high dependency risk, impose various dangers. One of the “side effects” of insomnia treatment is the development of drug dependence. Well-established methods of combating these issues concern only benzodiazepines, Z-drug medication use reduction protocols are still unavailable. However, considering both these drugs, a slow dose reduction method is believed to be the most effective and safe. The newest research examines the use of digital CBT as a tool for reducing drug dependence. The results are promising, as combining slow dose reduction with digital CBT yields better outcomes than the previous approach. However, there is still limited data on the use of digital CBT in reducing reliance on pharmacological interventions in high-risk patient groups or among patients with high levels of dependency, the development of official protocols is needed. This literature review aims to assess progress in this field of medicine. Review methods: This review is based on a non-systematic review of PubMed articles published between 2008 and 2026. Brief description of state knowledge: In numerous studies, the efficacy of digital CBT is a safe and effective method of insomnia treatment. Concerning previous addiction reduction methods, the only established guidelines are those concerning benzodiazepine dependency, and they involve the method of slow dose reduction. Recent clinical trials suggest that combining digital CBT with dose reduction may be an alternative, demonstrating greater efficacy in treating pharmacological dependence. Summary: Digital CBT-I is not only an alternative to traditional face-to-face CBT for the management of insomnia but may also represent a scalable and clinically relevant strategy for reducing benzodiazepine and Z-drug dependence. Emerging evidence suggests that combining gradual dose reduction with digital CBT-I may enhance deprescribing outcomes compared with tapering alone. However, limited real‑world safety data highlight the need for further research to define better safety and protocols for dependency reduction in patients overusing benzodiazepines and Z-drugs using digital CBT.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessDIGITAL COGNITIVE-BEHAVIORAL THERAPY FOR INSOMNIA (dCBT-I) AS A METHOD OF HYPNOTIC MEDICATION REDUCTION USE
Introduction & objective: Insomnia, being an established health problem, has led to the development of various ways of treatment. While Cognitive Behavioral Therapy is a gold standard of insomnia treatment, due to cost and accessibility limitations, pharmacological methods remain widely used. The most commonly used drugs are benzodiazepines and Z-drugs, which, due to their adverse effects and high dependency risk, impose various dangers. One of the “side effects” of insomnia treatment is the development of drug dependence. Well-established methods of combating these issues concern only benzodiazepines, Z-drug medication use reduction protocols are still unavailable. However, considering both these drugs, a slow dose reduction method is believed to be the most effective and safe. The newest research examines the use of digital CBT as a tool for reducing drug dependence. The results are promising, as combining slow dose reduction with digital CBT yields better outcomes than the previous approach. However, there is still limited data on the use of digital CBT in reducing reliance on pharmacological interventions in high-risk patient groups or among patients with high levels of dependency, the development of official protocols is needed. This literature review aims to assess progress in this field of medicine. Review methods: This review is based on a non-systematic review of PubMed articles published between 2008 and 2026. Brief description of state knowledge: In numerous studies, the efficacy of digital CBT is a safe and effective method of insomnia treatment. Concerning previous addiction reduction methods, the only established guidelines are those concerning benzodiazepine dependency, and they involve the method of slow dose reduction. Recent clinical trials suggest that combining digital CBT with dose reduction may be an alternative, demonstrating greater efficacy in treating pharmacological dependence. Summary: Digital CBT-I is not only an alternative to traditional face-to-face CBT for the management of insomnia but may also represent a scalable and clinically relevant strategy for reducing benzodiazepine and Z-drug dependence. Emerging evidence suggests that combining gradual dose reduction with digital CBT-I may enhance deprescribing outcomes compared with tapering alone. However, limited real‑world safety data highlight the need for further research to define better safety and protocols for dependency reduction in patients overusing benzodiazepines and Z-drugs using digital CBT.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
DIGITAL COGNITIVE-BEHAVIORAL THERAPY FOR INSOMNIA: SAFETY, LIMITATIONS, AND PATIENT-SPECIFIC CONTRAINDICATIONS
Introduction & objective: Insomnia is a well-established clinical problem that places a burden on the healthcare system. Due to low accessibility to professional therapists, high costs, and geographical barriers, cognitive-behavioural therapy, which is a first-line treatment for insomnia, is rarely prescribed in clinical practice. The development of digital CBT-I was aimed at overcoming those issues. However, there is still limited data regarding the safety and implementation of dCBT-I in real-life settings. Our aim was to select a specific patient group in which the traditional approach to CBT-I is preferred/advised. Review methods: This review is based on a non-systematic review of PubMed articles published between 2015 and 2026. Brief description of state knowledge: In numerous studies, dCBT-I has been proven to be an effective alternative to face-to-face therapy. It can be delivered in several technological forms and may vary in the level of therapist oversight. Although each form of digital CBT-I is to some extent automated, fully automated platforms raise the greatest concerns regarding safety and patient outcomes. Thus, some research suggests that there are patients for whom face-to-face therapy would be advisable. Summary: Digital CBT‑I with therapist oversight may be particularly important for patients with psychiatric disorders, epilepsy, obstructive sleep apnea, safety‑critical occupations, and older adults; however, limited real‑world safety data highlight the need for further research to better define high‑risk groups and refine clinical guidelines.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessDIGITAL COGNITIVE-BEHAVIORAL THERAPY FOR INSOMNIA: SAFETY, LIMITATIONS, AND PATIENT-SPECIFIC CONTRAINDICATIONS
Introduction & objective: Insomnia is a well-established clinical problem that places a burden on the healthcare system. Due to low accessibility to professional therapists, high costs, and geographical barriers, cognitive-behavioural therapy, which is a first-line treatment for insomnia, is rarely prescribed in clinical practice. The development of digital CBT-I was aimed at overcoming those issues. However, there is still limited data regarding the safety and implementation of dCBT-I in real-life settings. Our aim was to select a specific patient group in which the traditional approach to CBT-I is preferred/advised. Review methods: This review is based on a non-systematic review of PubMed articles published between 2015 and 2026. Brief description of state knowledge: In numerous studies, dCBT-I has been proven to be an effective alternative to face-to-face therapy. It can be delivered in several technological forms and may vary in the level of therapist oversight. Although each form of digital CBT-I is to some extent automated, fully automated platforms raise the greatest concerns regarding safety and patient outcomes. Thus, some research suggests that there are patients for whom face-to-face therapy would be advisable. Summary: Digital CBT‑I with therapist oversight may be particularly important for patients with psychiatric disorders, epilepsy, obstructive sleep apnea, safety‑critical occupations, and older adults; however, limited real‑world safety data highlight the need for further research to better define high‑risk groups and refine clinical guidelines.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
DARIDOREXANT IN THE TREATMENT OF INSOMNIA IN ELDERLY PATIENTS WITH COMORBIDITIES
Introduction and objective: Insomnia is one of the most prevalent sleep disorders in the adult population, thereby new methods of pharmacological treatment ought to be analyzed. Current novelty in insomnia treatment is daridorexant, a representative of the dual orexin receptor antagonist (DORA). Given that, the orexin system becomes overactive with age, explaining sleep of lower quality and quantity observed in older population, it is worth analysing the effect of the dual receptor antagonist (DORA) on the insomnia issue in older adults, and whether it proposes a safer choice among the existing pharmacological possibilities. Review methods: A comprehensive literature review was conducted, analyzing studies from the PubMed database of articles published between 2020 and 2025. Brief description of the state of knowledge: Insomnia treatment is based on both non-pharmacological and pharmacological methods. While among non-pharmacological methods cognitive-behavioral therapy is the one recommended, the choice of proper pharmacotherapy can impose more difficulties. The most commonly used medications, nonbenzodiazepine sedative hypnotics, lead to serious adverse effects and impose a risk of dependency. Daridorexant, a medication of proven efficacy, may propose a safer alternative, and furthermore, a more effective one. Summary: In this review, we decided to analyse the existing literature to present the current state of knowledge on the above-mentioned issue with a perspective of the future of this branch of medicine.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessDARIDOREXANT IN THE TREATMENT OF INSOMNIA IN ELDERLY PATIENTS WITH COMORBIDITIES
Introduction and objective: Insomnia is one of the most prevalent sleep disorders in the adult population, thereby new methods of pharmacological treatment ought to be analyzed. Current novelty in insomnia treatment is daridorexant, a representative of the dual orexin receptor antagonist (DORA). Given that, the orexin system becomes overactive with age, explaining sleep of lower quality and quantity observed in older population, it is worth analysing the effect of the dual receptor antagonist (DORA) on the insomnia issue in older adults, and whether it proposes a safer choice among the existing pharmacological possibilities. Review methods: A comprehensive literature review was conducted, analyzing studies from the PubMed database of articles published between 2020 and 2025. Brief description of the state of knowledge: Insomnia treatment is based on both non-pharmacological and pharmacological methods. While among non-pharmacological methods cognitive-behavioral therapy is the one recommended, the choice of proper pharmacotherapy can impose more difficulties. The most commonly used medications, nonbenzodiazepine sedative hypnotics, lead to serious adverse effects and impose a risk of dependency. Daridorexant, a medication of proven efficacy, may propose a safer alternative, and furthermore, a more effective one. Summary: In this review, we decided to analyse the existing literature to present the current state of knowledge on the above-mentioned issue with a perspective of the future of this branch of medicine.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
REVIEW OF THE NEW AVALANCHE RESCUE PROCEDURES ACCORDING TO THE NEW ERC 2025 GUIDELINES
Introduction and objective: Emergency medicine is nowadays a highly specialised branch of medicine. Regular updates on rescue procedures lead to the compilation of highly specialised guidelines. The rise in mobility among people encourages travel and participation in sports. Winter sports such as skiing and snowboarding increase the average time spent in mountain regions, thereby increasing the risk of avalanche exposure. To ensure high-quality avalanche rescue, official guidelines must be published and regularly revisited. Review Methods: A comprehensive literature review was conducted, analyzing studies indexed in PubMed and the official ERC Guidelines from 2021 and 2025. Brief description of the state of knowledge: The first official avalanche rescue guidelines were published in 2021 by the European Resuscitation Council. Since then, studies have examined their efficacy and sought better solutions. In 2022, a group of experts published an algorithm—Avalife—that outlined systematic, step-by-step Basic Life Support (BLS) recommendations in case of a shortage of rescuers at the site of an accident. The latest ERC Guidelines, published in 2025, introduce a new avalanche-rescue algorithm and incorporate the Avalife algorithm into official procedures, thereby establishing a cohesive avalanche-rescue policy. Summary: In this review, we analyse the existing literature, with particular emphasis on the new ERC 2025 Guidelines, to present the current state of knowledge on this issue.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessREVIEW OF THE NEW AVALANCHE RESCUE PROCEDURES ACCORDING TO THE NEW ERC 2025 GUIDELINES
Introduction and objective: Emergency medicine is nowadays a highly specialised branch of medicine. Regular updates on rescue procedures lead to the compilation of highly specialised guidelines. The rise in mobility among people encourages travel and participation in sports. Winter sports such as skiing and snowboarding increase the average time spent in mountain regions, thereby increasing the risk of avalanche exposure. To ensure high-quality avalanche rescue, official guidelines must be published and regularly revisited. Review Methods: A comprehensive literature review was conducted, analyzing studies indexed in PubMed and the official ERC Guidelines from 2021 and 2025. Brief description of the state of knowledge: The first official avalanche rescue guidelines were published in 2021 by the European Resuscitation Council. Since then, studies have examined their efficacy and sought better solutions. In 2022, a group of experts published an algorithm—Avalife—that outlined systematic, step-by-step Basic Life Support (BLS) recommendations in case of a shortage of rescuers at the site of an accident. The latest ERC Guidelines, published in 2025, introduce a new avalanche-rescue algorithm and incorporate the Avalife algorithm into official procedures, thereby establishing a cohesive avalanche-rescue policy. Summary: In this review, we analyse the existing literature, with particular emphasis on the new ERC 2025 Guidelines, to present the current state of knowledge on this issue.